Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.

The purpose of this study was to determine the safety, efficacy and impact on quality of life of recombinant human erythropoietin (r-HuEPO) for cancer patients undergoing radiotherapy (RT). An open-labelled randomized design was used, with patients randomized to either treatment or control arms. Pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sweeney, P. J., Nicolae, D., Ignacio, L., Chen, L., Roach, M., Wara, W., Marcus, K. C., Vijayakumar, S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150364/
https://www.ncbi.nlm.nih.gov/pubmed/9667681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150364/
https://www.ncbi.nlm.nih.gov/pubmed/9667681

Ejemplares similares